Yu Zeng

585 total citations
43 papers, 342 citations indexed

About

Yu Zeng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yu Zeng has authored 43 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Yu Zeng's work include RNA modifications and cancer (11 papers), Ferroptosis and cancer prognosis (10 papers) and Epigenetics and DNA Methylation (6 papers). Yu Zeng is often cited by papers focused on RNA modifications and cancer (11 papers), Ferroptosis and cancer prognosis (10 papers) and Epigenetics and DNA Methylation (6 papers). Yu Zeng collaborates with scholars based in China, United States and Hong Kong. Yu Zeng's co-authors include Jian Huang, Riken Chen, Wang Liu, Min Peng, Jun Yu, Zhenzhen Zheng, Jia Wang, Philip Wai Yan Chiu, Qiaoyi Liang and Linfei Hu and has published in prestigious journals such as Oncogene, Scientific Reports and Energy.

In The Last Decade

Yu Zeng

38 papers receiving 339 citations

Peers

Yu Zeng
Boqing Wang China
Mingzhu Bai China
Youguang Huang China
Yi Xue China
Isabelle Laverdière Canada
Binbin Yin China
Boxing Su China
Qiong Xiao China
Wenjing Liu China
Boqing Wang China
Yu Zeng
Citations per year, relative to Yu Zeng Yu Zeng (= 1×) peers Boqing Wang

Countries citing papers authored by Yu Zeng

Since Specialization
Citations

This map shows the geographic impact of Yu Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Zeng more than expected).

Fields of papers citing papers by Yu Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Zeng. The network helps show where Yu Zeng may publish in the future.

Co-authorship network of co-authors of Yu Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Zeng. A scholar is included among the top collaborators of Yu Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Zeng. Yu Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jianliang, Runsheng Xu, Laixin Wang, et al.. (2025). Effect of Fe2O3/CaO on pulverized coal combustion behavior and strengthening combustion mechanism. Energy. 321. 135103–135103. 1 indexed citations
2.
3.
Yang‐Hartwich, Yang, et al.. (2025). Ferroptosis-related signaling pathways in cancer drug resistance. Cancer Drug Resistance. 8(1). 1–1. 3 indexed citations
4.
Wang, Kecheng, Yu Zeng, Chunyan Yue, et al.. (2025). Epigenetic landscapes drive CAR-T cell kinetics and fate decisions: Bridging persistence and resistance. Critical Reviews in Oncology/Hematology. 211. 104729–104729. 2 indexed citations
5.
Liu, Min, Yu Liu, Yu Zeng, et al.. (2025). Programmed cell death-related gene IL20RA facilitates tumor progression and remodels tumor microenvironment in thyroid cancer. Scientific Reports. 15(1). 3520–3520. 1 indexed citations
6.
Zeng, Yu, Zhenju Song, Yinglu Liu, et al.. (2025). Genome-edited allogeneic CAR-T cells: the next generation of cancer immunotherapies. Journal of Hematology & Oncology. 18(1). 90–90. 1 indexed citations
7.
Gu, Pengfei, Jie Zhao, Wei Zhang, et al.. (2024). An Inducible CRISPR‐dCas9‐Based Transcriptional Repression System for Cancer Therapy. Small Methods. 8(8). e2301310–e2301310. 2 indexed citations
8.
Zhu, Jinfeng, Dongqiang Zeng, Yu Zeng, et al.. (2023). Epigenetic Modification-Associated Molecular Classification of Gastric Cancer. Laboratory Investigation. 103(9). 100170–100170.
9.
Zeng, Yu, Lijuan Li, Yu Liu, et al.. (2023). Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer. Aging. 15(5). 1668–1684. 4 indexed citations
10.
Fu, Siqi, Duan Liu, Yan Zhong, & Yu Zeng. (2023). Comparison of surgical excision followed by adjuvant radiotherapy and laser combined with steroids for the treatment of keloids: A systematic review and meta‐analysis. International Wound Journal. 21(3). e14449–e14449. 12 indexed citations
11.
12.
Wen, Jie, Yuyao Chen, Jing Huang, et al.. (2022). Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials. BMC Medicine. 20(1). 402–402. 29 indexed citations
13.
14.
Zeng, Yu, Zhenzhen Zheng, Riken Chen, et al.. (2021). A Pan-Cancer Analysis of the Prognostic Value and Expression of Adenylate Cyclase 7 (ADCY7) in Human Tumors. International Journal of General Medicine. Volume 14. 5415–5429. 7 indexed citations
15.
Zeng, Yu, Zhenzhen Zheng, Riken Chen, et al.. (2021). Screening of Hub Genes Associated with Pulmonary Arterial Hypertension by Integrated Bioinformatic Analysis. BioMed Research International. 2021(1). 6626094–6626094. 11 indexed citations
16.
Liu, Wang, et al.. (2021). Exploring the Potential Targets and Mechanisms of Huang Lian Jie Du Decoction in the Treatment of Coronavirus Disease 2019 Based on Network Pharmacology. International Journal of General Medicine. Volume 14. 9873–9885. 10 indexed citations
17.
Zeng, Yu, et al.. (2020). Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer. Journal of Cancer Research and Clinical Oncology. 146(6). 1379–1393. 29 indexed citations
18.
19.
Yu, Jun, Qiaoyi Liang, Jia Wang, et al.. (2016). REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype. Oncogene. 36(2). 182–193. 42 indexed citations
20.
Zeng, Yu. (2009). A simple solution route to control synthesis of Fe_3O_4 nanomaterials at low temperature and their magnetic properties. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boqing Wang Breakdown of academic impact, for papers by Mingzhu Bai Breakdown of academic impact, for papers by Youguang Huang Breakdown of academic impact, for papers by Yi Xue Breakdown of academic impact, for papers by Isabelle Laverdière Breakdown of academic impact, for papers by Binbin Yin Breakdown of academic impact, for papers by Boxing Su Breakdown of academic impact, for papers by Qiong Xiao Breakdown of academic impact, for papers by Wenjing Liu
Rankless by CCL
2026